Clinical review: Update on treatment of inflammatory macular edema. - Wikidata - awgldk - TriplyDB

Clinical review: Update on treatment of inflammatory macular edema.

Clinical review: Update on treatment of inflammatory macular edema.

http://www.wikidata.org/entity/Q37804876

about

Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis.Inflammation in retinal vein occlusion.Uveitic Macular Edema: Treatment Update.Sustained-release fluocinolone acetonide intravitreal insert for macular edema: clinical pharmacology and safety evaluation.Current Treatment Modalities of JIA-associated Uveitis and its Complications: Literature Review.Unmet Needs and Future Directions in Inflammatory Eye Disease.Cytokine and chemokine tear levels in patients with uveitis.Tocilizumab in Uveitic Macular Edema Refractory to Previous Immunomodulatory Treatment.Twenty-Four Months Follow-Up of Intravitreal Bevacizumab Injection versus Intravitreal Triamcinolone Acetonide Injection for the Management of Persistent Non-Infectious Uveitic Cystoid Macular Edema.

P2860

Q34530196-AF4C8FA2-A286-4BB4-B2D7-82504383CA5F Q34786343-B11CD950-B922-452B-9492-F839306C2F45 Q36802033-5D8F16E4-B815-45C9-9D4C-AFA3BBEAB22C Q37029324-1E87909F-1A4B-455B-A627-905D2B52FE7D Q38494605-72273492-A3F2-4086-BDCC-1D20D731AB27 Q38696180-2A487C20-48B6-4FF1-A791-A2E51EE7D4BD Q38806044-C1E5FE0B-97BC-4C90-B293-E1709A77BCBF Q48206476-6A5F0EC4-3088-4D5B-9106-2289D4D3A627 Q52858123-B8E88EAB-C6CE-4E99-8234-E8A09574ABD3 Q54313925-FF70C923-42F8-4C3B-88B8-7B8813D0A133

P2860

Clinical review: Update on treatment of inflammatory macular edema.

http://www.wikidata.org/entity/Q37804876

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 October 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical review: Update on treatment of inflammatory macular edema.

@en

Clinical review: Update on treatment of inflammatory macular edema.

@nl

type

label

Clinical review: Update on treatment of inflammatory macular edema.

@en

Clinical review: Update on treatment of inflammatory macular edema.

@nl

prefLabel

Clinical review: Update on treatment of inflammatory macular edema.

@en

Clinical review: Update on treatment of inflammatory macular edema.

@nl

P1433

Q37804876-2FA8608F-541C-4696-8FA7-6C4B737DCA18

P1476

Q37804876-7CB5E190-D3B3-497F-BF33-62780718B9DD

P2093

Q37804876-3440A005-1044-405B-80A9-A0437F1B8302

Q37804876-53FBB492-CA0E-413D-B7BC-2C2EDA7C9EEC

P2860

Q37804876-00E203E0-572B-49D9-8D63-A6230CF5941D

Q37804876-016EF02E-0CB6-434A-869F-D396508CA228

Q37804876-02D0C5BC-B83A-477E-83CE-ABC061CC0D94

Q37804876-035572F7-D985-4A2B-BF2A-75F32644636B

Q37804876-0513D5B8-FF88-467C-B69C-6D19782AC483

Q37804876-05E1D6F6-2AB3-47A3-99A0-E5B3D79A9C44

Q37804876-0888EACF-539A-4D57-86F2-288125FF8E0E

Q37804876-093F7243-F857-45C1-9418-8A1AA699BA74

Q37804876-0E115AF3-9F1B-4257-8418-3F535A28C5FF

Q37804876-10DF6E08-03BB-4745-8107-F76F2ACB1FD7

P304

Q37804876-C88D1897-2214-4A88-9F10-5CBA976B425D

P31

Q37804876-8A352761-4F46-4B3D-ABED-61049B9DA4AC

P356

Q37804876-A787F93B-3C23-48F5-B72B-BAAA59B678F2

P433

Q37804876-9028E45D-AD69-4AD7-BCAB-B790D1330E20

P478

Q37804876-BC40A20D-6D83-4D3D-8B4C-622FF2A1DF19

P577

Q37804876-AC188627-5D13-45FA-952C-738EC063B61D

P698

Q37804876-549CCEC4-EB34-4395-96C7-CFDE48CB79A1

P921

Q37804876-F6AE1228-0C96-4535-BFB7-C64B98518BA0

P356

09273948.2010.509530

P1433

Ocular Immunology and Inflammation

P1476

Clinical review: Update on treatment of inflammatory macular edema.

@en

P2093

Aniki Rothova

http://www.w3.org/2001/XMLSchema#string

Annette Ossewaarde-van Norel

http://www.w3.org/2001/XMLSchema#string

P2860

Ranibizumab for neovascular age-related macular degeneration

Grid laser photocoagulation for macular oedema in uveitis or the Irvine-Gass syndrome.

Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis.

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

Bevacizumab in inflammatory eye disease

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

The effect of pars plana vitrectomy on cystoid macular oedema associated with chronic uveitis: a randomised, controlled pilot study.

The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.

Pars plana vitrectomy with intravitreal triamcinolone: effect on uveitic cystoid macular oedema and treatment limitations.

Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients

P304

75-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/09273948.2010.509530

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21034302

http://www.w3.org/2001/XMLSchema#string

P921